1-[4-(Acridin-9-ylamino)-phenyl]-3-[4-(5-amino-pentyl)-phenyl]-urea dihydrochloride

ID: ALA1204333

Chembl Id: CHEMBL1204333

PubChem CID: 52944145

Max Phase: Preclinical

Molecular Formula: C31H33Cl2N5O

Molecular Weight: 489.62

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.Cl.NCCCCCc1ccc(NC(=O)Nc2ccc(N=c3c4ccccc4[nH]c4ccccc34)cc2)cc1

Standard InChI:  InChI=1S/C31H31N5O.2ClH/c32-21-7-1-2-8-22-13-15-24(16-14-22)34-31(37)35-25-19-17-23(18-20-25)33-30-26-9-3-5-11-28(26)36-29-12-6-4-10-27(29)30;;/h3-6,9-20H,1-2,7-8,21,32H2,(H,33,36)(H2,34,35,37);2*1H

Standard InChI Key:  OXIWFWFCHUDCEG-UHFFFAOYSA-N

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus sp. (1192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 489.62Molecular Weight (Monoisotopic): 489.2529AlogP: 6.87#Rotatable Bonds: 8
Polar Surface Area: 95.30Molecular Species: BASEHBA: 3HBD: 4
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.64CX Basic pKa: 10.19CX LogP: 6.80CX LogD: 4.35
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.14Np Likeness Score: -0.48

References

1. Denny WA, Cain BF, Atwell GJ, Hansch C, Panthananickal A, Leo A..  (1982)  Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.,  25  (3): [PMID:7069706] [10.1021/jm00345a015]

Source